ArticleChinese medicine2025
Epigenetic control of the plant metabolome: implications for Chinese medicine.
Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Epigenetic regulation-including DNA methylation, histone modifications, and small RNAs-plays a crucial role in modulating specialized metabolism in plants; specialized metabolites confer crucial pharmacological properties to plants, forming the basis of traditional Chinese medicine (TCM). Recent studies have highlighted the influence of these mechanisms on metabolite production in key medicinal plants such as Papaver somniferum and Salvia miltiorrhiza. Emerging technologies such as CRISPR/dCas9-based epigenome editing and miRNA modulation enable precise control of biosynthetic pathways. Integrating these molecular-level strategies into TCM research and the cultivation of medicinal plants could improve the efficacy and consistency of herbal medicinal products, providing molecular tools for the targeted regulation of active ingredients and thereby facilitating the modernization of TCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.